Market Tracker

10/31 1:52pm ET

Rexahn Pharmaceuticals Inc (NYSE MKT LLC:RNN)

0.7152
Data as of 1:26pm ET
 -0.0143 / -1.96%
Today’s Change
0.37
Today|||52-Week Range
1.85
+40.24%
Year-to-Date
No recent news for Rexahn Pharmaceuticals Inc.

Today’s Trading

Previous close0.73
Today’s open0.71
Day’s range0.71 - 0.73
Volume333,650
Average volume (3 months)991,460
Market cap$130.0M
Dividend yield--
Data as of 1:26pm ET, 10/31/2014

Growth & Valuation

Earnings growth (last year)-16.67%
Earnings growth (this year)-90.48%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book8.48

Competitors

 Today’s
change
Today’s
% change
CRMECardiome Pharma Corp-0.10-1.19%
GLYCGlycoMimetics Inc+0.12+1.74%
MDWDMediwound Ltd-0.09-1.52%
INNLInnocoll AG+0.27+3.96%
Data as of 1:37pm ET, 10/31/2014

Financials

Next reporting dateDecember 3, 2014
EPS forecast (this quarter)-$0.02
Annual revenue (last year)$0.00
Annual profit (last year)-$9.5M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Scientist
Chang Ho Ahn
Chief Executive Officer &
Director
Peter David Suzdak
Corporate headquarters
Rockville, Maryland

Forecasts